Playing ice hockey and basketball increases serum levels of S-100B in elite players: A pilot study

Clinical Journal of Sport Medicine

Volumn 13, Issue 5, 2003, Pages 292-302

  Stålnacke, Britt Marie ^a   Tegner, Yelverton ^b   Sojka, Peter ^a,c  

^a UMEÅ UNIVERSITY   (Sweden)

^b LULEÅ UNIVERSITY OF TECHNOLOGY   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Basketball; Brain injury; Concussion; Head injury; Ice hockey; Sport

Indexed keywords

BIOCHEMICAL MARKER; BIOLOGICAL MARKER; ENOLASE; NERVE TISSUE PROTEIN S 100B; NEURON SPECIFIC ENOLASE; PROTEIN S 100; PROTEIN S100B;

ACCELERATION; ADULT; ARTICLE; BASKETBALL; BLOOD; BLOOD LEVEL; BRAIN INJURY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPETITIVE BEHAVIOR; CONCUSSION; DECELERATION; DECISION MAKING; DIAGNOSTIC VALUE; FOLLOW UP; HEAD INJURY; HUMAN; ICE HOCKEY; IMMUNOASSAY; JUMPING; LUMINESCENCE IMMUNOASSAY; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; PROTEIN SECRETION; SPORT; SPORT INJURY; SYMPTOMATOLOGY;

ACCELERATION; ADULT; ATHLETIC INJURIES; BASKETBALL; BIOLOGICAL MARKERS; COMPETITIVE BEHAVIOR; FOLLOW-UP STUDIES; HEAD INJURIES, CLOSED; HOCKEY; HUMANS; MALE; NERVE GROWTH FACTORS; PHOSPHOPYRUVATE HYDRATASE; PILOT PROJECTS; S100 PROTEINS;

EID: 16744365112     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042752-200309000-00004     Document Type: Article

References (52)

1. Sosin DM, Sniezek JE, Waxweiler RJ. Trends in death associated with traumatic brain injury, 1979 through 1992: success and failure. JAMA. 1995;273:1778-1780.
2. Practice parameter: the management of concussion in sports (summary statement). Report of the Quality Standards Subcommittee. Neurology. 1997;48:581-585.
3. Alexander MP. Mild traumatic brain injury: pathophysiology, natural history, and clinical management. Neurology. 1995;45:1253-1260.
4. Gasquoine PG. Postconcussion symptoms. Neuropsychol Rev. 1997;7:77-85.
5. Cantu RC. Head injuries in sport. Br J Sports Med. 1996;30:289-296.
6. Rabadi MH, Jordan BD. The cumulative effect of repetitive concussion in sports. Clin J Sport Med. 2001;11:194-198.
7. Lye TC, Shores EA. Traumatic brain injury as a risk factor for Alzheimer's disease: a review. Neuropsychol Rev. 2000;10:115-129.
8. Goodman D, Gaetz M, Meichenbaum D. Concussions in hockey: there is cause for concern. Med Sci Sports Exerc. 2001;33:2004-2009.
9. Jorgensen U, Schmidt-Olsen S. The epidemiology of ice hockey injuries. Br J Sports Med. 1986;20:7-9.
10. Biasca N, Simmen HP, Bartolozzi AR, et al. Review of typical ice hockey injuries: survey of the North American NHL and Hockey Canada versus European leagues. Unfallchirurg. 1995;98:283-288.
11. Tegner Y, Lorentzon R. Concussion among Swedish elite ice hockey players. Br J Sports Med. 1996;30:251-255.
12. Kelly JP, Rosenberg JH. Diagnosis and management of concussion in sports. Neurology. 1997;48:575-580.
13. McCrory PR. You can run but you can't hide: the role of concussion severity scales in sport. Br J Sports Med. 1999;33:297-298.
14. Aubry M, Cantu R, Dvorak J, et al. Summary and agreement statement of the First International Conference on Concussion in Sport, Vienna 2001: recommendations for the improvement of safety and health of athletes who may suffer concussive injuries. Br J Sports Med. 2002;36:6-10.
15. Zimmer DB, Cornwall EH, Landar A, et al. The S100 protein family: history, function, and expression. Brain Res Bull. 1995;37:417-429.
16. Marangos PJ, Schmechel DE. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci. 1987;10:269-295.
17. Herrmann M, Jost S, Kutz S, et al. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma. 2000;17:113-122.
18. Böttinger BW. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation. 2001;103:2694-2698.
19. Pleines UE, Morganti-Kossmann MC, Rancan M, et al. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma. 2001;18:491-498.
20. Woertgen C, Rothoerl RD, Holzschuh M, et al. Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir. 1997;139:1161-1164.
21. Skogseid IM, Nordby HK, Urdal P, et al. Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage. Acta Neurochir (Wien). 1992;115:106-111.
22. Yamazaki Y, Yada K, Morii S, et al. Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg Neurol. 1995;43:267-271.
23. Ergun R, Bostanci U, Akdemir G, et al. Prognostic value of serum neuron-specific enolase levels after head injury. Neurol Res. 1998;20:418-420.
24. Berger RP, Pierce MC, Wisniewski SR, et al. Neuronspecific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics. 2002;109:E31.
25. Persson L, Hardemark HG, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke. 1987;18:911-918.
26. Persson L, Hardemark H, Edner G, et al. S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: a potential marker of brain damage. Acta Neurochir (Wien). 1988;93:116-122.
27. Hardemark HG, Almqvist O, Johansson T, et al. S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction. Acta Neurochir (Wien). 1989;99:135-144.
28. Missler U, Wiesmann M, Ehlermann P, et al. Validation and comparison of two solid-phase immunoassays for the quantification of S-100B in human blood. Clin Chem. 2000;46:993-996.
29. de Vries J, Thijssen WA, Snels SE, et al. Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients. J Neurol Neurosurg Psychiatry. 2001;71:671-674.
30. Raabe A, Grolms C, Sorge O, et al. Serum S-100B protein in severe head injury. Neurosurgery. 1999; 45:477-483.
31. Rothoerl RD, Woertgen C, Holzschuh M, et al. Rapid evaluation of S-100 serum levels: case report and comparison to previous results. Brain Inj. 1999;13:387-391.
32. Romner B, Ingebrigtsen T, Kongstad P, et al. Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J Neurotrauma. 2000;17:641-647.
33. Shaaban Ali M, Harmer M, Vaughan RS, et al. Early release pattern of S100 protein as a marker of brain damage after warm cardiopulmonary bypass. Anaesthesia. 2000;55:802-806.
34. Waterloo K, Ingebrigtsen T, Romner B. Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury. Acta Neurochir. 1997;139:26-31.
35. Herrmann M, Curio N, Jost S, et al. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry. 2001;70:95-100.
36. Otto M, Holthusen S, Bahn E, et al. Boxing and running lead to a rise in serum levels of S-100B protein. Int J Sports Med. 2000;21:551-555.
37. King NS, Crawford S, Wenden FJ, et al. The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol. 1995;242:587-592.
38. Crawford S, Wenden FJ, Wade DT. The Rivermead head injury follow up questionnaire: a study of a new rating scale and other measures to evaluate outcome after head injury. J Neurol Neurosurg Psychiatry. 1996;60:510-514.
39. Anderson RE, Hansson LO, Nilsson O, et al. High serum S100B levels for trauma patients without head injuries. Neurosurgery. 2001;48:1255-1260.
40. de Kruijk JR, Leffers P, Menheere PP, et al. S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients: a comparison with health controls. Acta Neurol Scand. 2001;103:175-179.
41. LIAISON SANGTEC 100. Bromma, Sweden: AB Sangtec Medical, 2001.
42. Ingebrigtsen T, Romner B, Marup-Jensen S, et al. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj. 2000;14:1047-1055.
43. Ingebrigtsen T, Waterloo K, Jacobsen EA, et al. Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery. 1999;45:468-476.
44. Haimoto H, Hosoda S, Kato K. Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues. Lab Invest. 1987;57:489-498.
45. Barzo P, Marmarou A, Fatouros P, et al. Acute blood-brain barrier changes in experimental closed head injury as measured by MRI and Gd-DTPA. Acta Neurochir Suppl. 1997;70:243-246.
46. Kapural M, Krizanac-Bengez L, Barnett G, et al. Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Res. 2002;940:102-104.
47. Linstedt U, Meyer O, Kropp P, et al. Serum concentration of S-100 protein in assessment of cognitive dysfunction after general anesthesia in different types of surgery. Acta Anaesthesiol Scand. 2002;46:384-389.
48. Sturmi JE, Smith C, Lombardo JA. Mild brain trauma in sports: diagnosis and treatment guidelines. Sports Med. 1998;25:351-358.
49. Cantu RC. Overview of concussion. In: Cantu RC, ed. Neurologic Athletic Head and Spine Injuries. Philadelphia: WB Saunders, 2000:76-79.
50. McCrory PR. Were you knocked out? A team physician's approach to initial concussion management. Med Sci Sports Exerc. 1997;29:S207-S212.
51. Leclerc S, Lassonde M, Dupuis F, et al. Concussion in the elite athlete: new evaluation, grading system and return to play guidelines. Med Sci Sports Exerc. 1999;31.
52. Erlanger D, Saliba E, Barth J, et al. Monitoring resolution of postconcussion symptoms in athletes: preliminary results of a Web-based neuropsychological test protocol. J Athletic Training. 2001;36:280-292.